P2RX7B is a new theranostic marker for lung adenocarcinoma patients

Rationale: The characterization of new theranostic biomarkers is crucial to improving the clinical outcome of patients with advanced lung cancer. Here, we aimed at characterizing the P2RX7 receptor, a positive modulator of the anti-tumor immune response, in patients with lung adenocarcinoma. Methods...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Benzaquen, Jonathan, Dit Hreich, Serena Janho, Heeke, Simon, Juhel, Thierry, Lalvee, Salomé, Bauwens, Serge, Saccani, Simona, Lenormand, Philippe, Hofman, Véronique, Butori, Mathilde, Leroy, Sylvie, Berthet, Jean-Philippe, Marquette, Charles-Hugo, Hofman, Paul, Vouret-Craviari, Valérie
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7532666/
https://ncbi.nlm.nih.gov/pubmed/33042257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.48229
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados